Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
My blood pressure is controlled on a near-homeopathic dose of medication
7.3 Roche/Herceptin Portfolio Architecture Case Study Genentech (Roche) built the trastuzumab franchise into a HER2 therapeutic platform with over 1,500 patents across Herceptin, Perjeta (pertuzumab), Kadcyla (ado-trastuzumab emtansine), and Phesgo (pertuzumab/trastuzumab fixed-dose combination)
Oral tirzepatide may have a similar side-effect profile, but no published data exist yet
The BMI considerations for GLP-1 therapy extend beyond initial qualification and into decisions about treatment duration
US$ 21.66
US$ 26.37
US$ 29.60
US$ 21.63
